Postpartum Low-Dose Aspirin and Preeclampsia
common.study.values.description
“Postpartum Low-Dose Aspirin and Preeclampsia”
The purpose of this research study is to find out whether women with severe preeclampsia taking low-dose aspirin (LDA) for 3 weeks post-delivery will experience an improvement in endothelial function (measured as flow-mediated dilation - FMD) and severity of disease, as the effects of preeclampsia can persist postpartum. Women diagnosed with severe preeclampsia prior to delivery will be enrolled and randomized to receive either low-dose aspirin (81mg) or placebo to take daily for up to 3 weeks post-delivery.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Aspirin
Low dose aspirin, 81mg tablets, PO
Drug - Placebo oral capsule
Placebo oral capsule, PO
participant.views.study.view.additional
participant.views.study.view.scientific-title
Low-Dose Aspirin in the Postpartum Period and Endothelial Function in Patients With Preeclampsia
common.study.values.clinical-trial-id
NCT03667326
participant.views.study.view.id
dL9ZAe
